Article

Ophthalmologists face several public policy issues, AAO official says

When the Centers for Medicare and Medicaid Services (CMS) publishes reports on the physicians who participate in the Physician Quality Reporting Initiative, patients may be suspicious of physicians who don?t participate, said William Rich III, MD, medical director of health policy, American Academy of Ophthalmology (AAO). He provided the perspective of the practitioner during a mini-symposium on glaucoma public policy.

When the Centers for Medicare and Medicaid Services (CMS) publishes reports onthe physicians who participate in the Physician Quality Reporting Initiative, patients may besuspicious of physicians who don't participate, said William Rich III, MD, medical director ofhealth policy, American Academy of Ophthalmology (AAO). He provided the perspective of thepractitioner during a mini-symposium on glaucoma public policy.

He also said that the transactional approach to health care, wherein a physician provides aservice and then is paid, is changing to a system that recognizes efficiency in care.

The drive for enhanced quality measures with an emphasis on outcomes is here to stay, Dr. Richsaid. Any system measuring quality and outcomes, however, be it in the public or privatesector, should recognize (in the case of eye care) that some ophthalmologists aresubspecialists for whom the majority of patients have more serious conditions than those seenby general ophthalmologists or optometrists. Not all systems have this ability right now, headded.

"We have to get consumer groups involved," Dr. Rich said.

The public policy issues related to glaucoma that Dr. Rich addressed included the use ofeconomic profiling, the overvaluation of services, the search for a new fix for the sustainablegrowth rate, the increased scrutiny of new devices, and relations with industry. On the latterpoint, Dr. Rich said, ophthalmologists should examine their individual relationships withindustry. Pressure to report the receipt of meals, drug samples, pens, and the like, isincreasing, he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.